Physician profile
Charles Alan Block
NPI 1073501581
$1,390.22
in general payments reported to CMS, 2019-2025
17 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $205 · 2021: $257 · 2022: $263 · 2023: $134 · 2024: $73.11 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $390.02 | 2019-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $239.45 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $200.02 | 2019-2025 | |
| Pfizer INC. | $146.81 | 2020-2023 | |
| Sanofi-Aventis U.S. LLC | $97.12 | 2023-2025 | |
| Cranial Technologies, INC | $63.53 | 2021-2023 | Doc Band |
| Tris Pharma INC | $54.21 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $45.52 | 2025 | Jornay Pm |
| Seqirus USA INC | $32.37 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $21.23 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.64 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.32 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.58 | 2019 | |
| Sobi, INC | $14.51 | 2019 | |
| Mission Pharmacal Company | $14.37 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $13.47 | 2019 | |
| Hologic Sales and Service, LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Block listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.